Chuck Sholtz has over 30 years of IP experience representing clients in both law firm and corporate settings in patent and other intellectual property matters. He is currently Head of Intellectual Property at Verdiva Bio and co-teaches a Biotechnology Law class at Santa Clara University School of Law. Prior to Verdiva Bio, Chuck served in Intellectual Property leadership positions at Nutcracker Therapeutics, Genentech, Coherus Biosciences, and Amgen. At Genentech, Chuck led teams supporting Avastin, Herceptin and Rituxan, as well as Genentech’s cell culture, process development and manufacturing organizations. Chuck also participated on the team managing Genentech’s response in the JHL trade secrets misappropriations case. Chuck earned a B.S. in Cell & Molecular Biology and a B.S.E. in Engineering Science (Bioengineering) from the University of Michigan, a Masters degree in Physiology from Yale University, a Ph.D. in Neuroscience from Stanford University, and a J.D. from Santa Clara University.